“… 1 , 2 , 3 , 4 , 5 , 6 , 7 Experimental investigations have offered various mechanistic insights into the renoprotective effects of SGLT2 inhibitors for early DKD through blood glucose lowering-dependent and -independent pathways, 8 such as reductions in oxidative stress, 9 , 10 improvements in glomerular hyperfiltration, 10 , 11 energy utilization by ketone body production, 12 and tissue hypoxia. 10 , 13 We and other researchers demonstrated that SGLT2 inhibitors attenuated decreases in tissue oxygen tension in the early diabetic kidney, which was attributed to the inhibition of sodium reabsorption reducing energy requirements through basolateral Na-K ATPase. 10 , 13 , 14 , 15 …”